127. Patsch, W. Postprandial lipemia and coronary risk / W. Patsch, G. Meisenbock,
T. Hopferweisew, et al. // Curr Atheroscler Rep. —2000. - Vol. 2. - P.232-242.
128. Pearson, T.A. American Heart Association guidelines for primary prevention of
cardiovascular disease and stroke: 2002 update: consensus panel guide to
comprehensive risk reduction for adult patients without coronary or other
atherosclerotic vascular diseases. American Heart Association Science Advisory
and Coordinating Committee / T.A. Pearson, S.N. Blair, S.R. Daniels, et al. //
Circulation. - 2002. - Vol. 106. - P.388-391.
129. Pearson, T.A. Markers of inflammation and cardio-vascular disease: application
to clinical and public health practice: a statement for healthcare professionals
from the Centers for Disease Control and Prevention and the American Heart
Association / T.A. Pearson, G.A. Mensah, R.W. Alexander, et al. // Circulation. -
2003.-V o l. 107. - P.499-511.
130. Pedersen, T.R. Lipoprotein changes and reduction in the incidence of major
coronary events in the Scandinavian Simvastatin Survival Study / T.R. Pedersen,
A.G. Olsson, O. Faergeman, et al. // Circulation. - 1998. - Vol. 97. - P. 1453-
1460.
131. Pepys, M.B. C-reactive protein: a critical update / M.B. Pepys, G.M. Hirschfield
// J Clin Invest. - 2003. - Vol. 111. - P. 1805-1812.
132. Pereira, M.A. A randomized walking trial in postmenopausal women / M.A.
Pereira, A.N. Kriska, R.D. Day, et al. // Arch Intern Med. -1998. - Vol. 158. -
P .1695-1701.
133. Pignone, M. Use of lipid lowering drugs for primary prevention of coronary heart
disease: meta-analysis of randomized trials / M. Pignone, C. Phillips, C. Murlow
// BMJ. - 2000. - Vol. 3 2 1 ,- P.983-986.
134. Portman O. Dietary regulation of serum cholesterol levels // O. Portman //
Physiol Rev. - 1959. - Vol. 39 (3). - P.407-442.
135. Randomized trial of cholesterol lowering in 4444 patients with heart disease: the
Scandinavian Simvastatin Survival Study (4S) // Lancet. - 1994. - Vol. 344. —
P.l 383— 1389.
97
